PEDIATRICS Vol. 89 No. 4 April 1992, pp. 795-800
This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Universal Hepatitis B Immunization

Committee on Infectious Diseases

HEPATITIS B DISEASE AND EPIDEMIOLOGY

In the United States 200 000 to 300 000 acute infections with hepatitis B virus (HBV) occur each year.1,2 More than one million persons in the United States have chronic HBV infection, and approximately 4000 to 5000 persons die each year from HBV-induced chronic liver disease and hepatocellular carcinoma. Although HBV infections occur during childhood and adolescence, the full impact of these infections is not recognized until many years later when chronic liver disease and hepatocellular carcinoma may develop. The incidence of HBV infection increases rapidly during adolescence, with higher rates among blacks than among whites (Fig 1).3 Although rates vary by region, sex, and race, between 3.3% and 25% of all persons have had HBV infection by 25 to 34 years of age. The likelihood of becoming chronically infected with HBV varies inversely with the age at which infection occurs. HBV transmitted from hepatitis B surface antigen (HBsAg)-positive mothers to their newborns results in HBV carriage for up to 90% of infants. Between 25% and 50% of children infected before 5 years of age become carriers, whereas only 6% to 10% of acutely infected adults become carriers. It is estimated that more than 25% of carrier infants will die from primary hepatocellular carcinoma or cirrhosis of the liver, with most of these deaths occurring during adult life.

HBV infection occurs more commonly in certain populations, including Pacific Islanders, Alaskan Natives, immigrants from countries in which infection is highly endemic, persons who require multiple transfusions of blood or blood products, and persons with high-risk lifestyles, including intravenous drug abuse and contact with multiple sexual partners.




This article has been cited by other articles:


Home page
 PediatricsHome page
C. E. Mercier, S. E. Barry, K. Paul, T. V. Delaney, J. D. Horbar, R. C. Wasserman, P. Berry, and J. S. Shaw
Improving Newborn Preventive Services at the Birth Hospitalization: A Collaborative, Hospital-Based Quality-Improvement Project
Pediatrics, September 1, 2007; 120(3): 481 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
D. B. HIPGRAVE, N. T. VAN, V. M. HUONG, H. T. LONG, D. T. DAT, T. N. TRUNG, D. JOLLEY, J. E. MAYNARD, and B.-A. BIGGS
HEPATITIS B INFECTION IN RURAL VIETNAM AND THE IMPLICATIONS FOR A NATIONAL PROGRAM OF INFANT IMMUNIZATION
Am J Trop Med Hyg, September 1, 2003; 69(3): 288 - 294.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. N. Saari and and Committee on Infectious Diseases
Immunization of Preterm and Low Birth Weight Infants
Pediatrics, July 1, 2003; 112(1): 193 - 198.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
K. D. Aiken, S. J. Clark, and M. D. Cabana
Reasons Hospitals Give for Not Offering Hepatitis B Vaccine to Low-Risk Newborns
Clinical Pediatrics, November 1, 2002; 41(9): 681 - 686.
[Abstract] [PDF]

Home page
 PediatricsHome page
I. M. Gonzalez, F. M. Averhoff, M. S. Massoudi, H. Yusuf, F. DeStefano, P. Kramarz, J. E. Maher, J. P. Mullooly, C. Chun, R. L. Davis, et al.
Hepatitis B Vaccination Among Adolescents in 3 Large Health Maintenance Organizations
Pediatrics, November 1, 2002; 110(5): 929 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
P. H. Dennehy
Active Immunization in the United States: Developments over the Past Decade
Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
N. A. Halsey and L. Goldman
Balancing Risks and Benefits: Primum non nocere Is Too Simplistic
Pediatrics, August 1, 2001; 108(2): 466 - 467.
[Full Text]

Home page
 JAMAHome page
R. J. Oram, R. S. Daum, J. B. Seal, and D. S. Lauderdale
Impact of Recommendations to Suspend the Birth Dose of Hepatitis B Virus Vaccine
JAMA, April 11, 2001; 285(14): 1874 - 1879.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. B. Hurie, T. N. Saari, and J. P. Davis
Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on Thimerosal in Vaccines on Hospital Infant Hepatitis B Vaccination Practices
Pediatrics, April 1, 2001; 107(4): 755 - 758.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
R. Brayden, K. A. Pearson, A. Kempe, J. F. Steiner, and S. Berman
Hepatitis B Vaccine Administration and Communication Policies in Rural Colorado Hospitals
Clinical Pediatrics, December 1, 2000; 39(12): 723 - 726.
[PDF]

Home page
 Arch Pediatr Adolesc MedHome page
H. Lancman, D. R. Pastore, N. Steed, and A. Maresca
Adolescent Hepatitis B Vaccination: Comparison Among 2 High School-Based Health Centers and an Adolescent Clinic
Arch Pediatr Adolesc Med, November 1, 2000; 154(11): 1085 - 1088.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
H. R. Yusuf, D. Daniels, P. Smith, V. Coronado, and L. Rodewald
Association Between Administration of Hepatitis B Vaccine at Birth and Completion of the Hepatitis B and 4:3:1:3 Vaccine Series
JAMA, August 23, 2000; 284(8): 978 - 983.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. F. Maillefert, J. Sibilia, E. Toussirot, E. Vignon, J. P. Eschard, B. Lorcerie, R. Juvin, N. Parchin-Geneste, C. Piroth, D. Wendling, et al.
Rheumatic disorders developed after hepatitis B vaccination
Rheumatology, October 1, 1999; 38(10): 978 - 983.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. A. Losonsky, S. S. Wasserman, I. Stephens, F. Mahoney, P. Armstrong, K. Gumpper, S. Dulkerian, D. J. West, and I. H. Gewolb
Hepatitis B Vaccination of Premature Infants: A Reassessment of Current Recommendations for Delayed Immunization
Pediatrics, February 1, 1999; 103(2): 14e - 14.
[Abstract] [Full Text]

Home page
 Med Decis MakingHome page
T. Wiebe, P. Fergusson, D. Horne, M. Shanahan, A. Macdonald, L. Heise, and L. L. Roos
Hepatitis B Immunization in a Low-incidence Province of Canada: Comparing Alternative Strategies
Med Decis Making, October 1, 1997; 17(4): 472 - 482.
[Abstract] [PDF]

Home page
 PediatricsHome page
S. C. Kim, E. K. Chung, R. L. Hodinka, J. DeMaio, D. J. West, A. F. Jawad, and B. Watson
Immunogenicity of Hepatitis B Vaccine in Preterm Infants
Pediatrics, April 1, 1997; 99(4): 534 - 536.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
E. A. Mattey
Hepatitis B Vaccine: For School Staff At Risk
The Journal of School Nursing, February 1, 1997; 13(1): 4 - 8.
[Abstract] [PDF]

Home page
 The Journal of the Royal Society for the Promotion of HealthHome page
M. Feely
Hepatitis and hepatitis immunisation
The Journal of the Royal Society for the Promotion of Health, February 1, 1997; 117(1): 41 - 46.


Home page
 Journal of Pharmacy PracticeHome page
H. J. Vosper
Pediatric Immunization: Current Recommendations and Controversies
Journal of Pharmacy Practice, February 1, 1996; 9(1): 14 - 26.
[Abstract] [PDF]

Home page
 Am J Sports MedHome page
Human Immunodeficiency Virus (HIV) and Other Blood-Borne Pathogens in Sports: Joint Position Statement
Am. J. Sports Med., July 1, 1995; 23(4): 510 - 514.
[PDF]

Home page
 CLIN PEDIATRHome page
J. Gindler, S. C. Hadler, P. M. Strebel, and J. C. Watson
Recommended Childhood Immunization Schedule: United States 1995
Clinical Pediatrics, February 1, 1995; 34(2): 66 - 72.
[PDF]

Home page
 NEJMHome page
R. J. Kim-Farley, M. H. Merson, J. L. Tulloch, F. Deisenhammer, P. Pohl, G. Grubwieser, S. Sepkowitz, and G. Peter
Childhood Immunizations
N. Engl. J. Med., May 13, 1993; 328(19): 1420 - 1422.
[Full Text]